Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study
Hemodialysis International, 11/05/09
Kessler M et al. – C.E.R.A., a continuous erythropoietin receptor activator is approved for the treatment of anemia in patients with chronic kidney disease (CKD). The ARCTOS (administration of C.E.R.A. in CKD patients to treat anemia with a twice–monthly schedule) phase 3 study demonstrated the efficacy and safety of C.E.R.A. in correcting anemia when administered once every 2 weeks (Q2W) subcutaneously in patients with CKD not on dialysis. All treatments were well tolerated. Subcutaneous C.E.R.A. Q4W is safe and effective in maintaining stable Hb levels in patients with CKD not on dialysis following correction with subcutaneous C.E.R.A. Q2W.
Related Articles
Understanding Diabetes Mellitus And Kidney Disease
Nephrology Nursing Journal, 10/02/09
Relevance Score: 83%
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial
Nephrology Dialysis Transplantation, 11/17/09
Relevance Score: 82%
Diabetic kidney disease in the older adult: an update
Aging Health, 10/07/09
Relevance Score: 82%
The Intersection of Geriatrics and Chronic Kidney Disease: Frailty and Disability Among Older Adults With Kidney Disease
Advances In Chronic Kidney Disease, 10/07/09
Relevance Score: 82%
So Just What Can I Eat? Nutritional Care in Patients with Diabetes Mellitus and Chronic Kidney Disease
Nephrology Nursing Journal, 10/06/09
Relevance Score: 82%
Today in Chronic Dz/Renal Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
CMV Seropositivity Determines Epoetin Dose and Hemoglobin Levels in Patients with CKD
Journal of the American Society of Nephrology, 11/24/09
Rapid Decline of Kidney Function Increases Cardiovascular Risk in the Elderly
Journal of the American Society of Nephrology, 11/23/09
Masked Hypertension Associates with Left Ventricular Hypertrophy in Children with CKD
Journal of the American Society of Nephrology, 11/23/09
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study
Nephrology Dialysis Transplantation, 11/24/09
Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients
Nephrology Dialysis Transplantation, 11/24/09
An integrin-activating peptide, PHSRN, ameliorates inhibitory effects of conventional peritoneal dialysis fluids on peritoneal wound healing
Nephrology Dialysis Transplantation, 11/20/09
Article Search
Sponsor


See Latest Articles


